Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03819465
Title A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC (MAGELLAN)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Gemcitabine

Durvalumab + Oleclumab

Carboplatin

Pemetrexed Disodium

Nab-paclitaxel

AZD9150 + Durvalumab

Cisplatin

Durvalumab

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.